Disc Medicine (IRON) Common Equity (2020 - 2026)

Disc Medicine (IRON) has 7 years of Common Equity data on file, last reported at $688.4 million in Q1 2026.

• On a quarterly basis, Common Equity rose 4.25% year-over-year to $688.4 million in Q1 2026; TTM through Mar 2026 was $688.4 million, a 4.25% increase from a year earlier, with the FY2025 full-year figure at $739.8 million, up 66.78% from the prior year.
• Common Equity for Q1 2026 stood at $688.4 million, down from $739.8 million in the prior quarter.
• Over the last five years, Common Equity for IRON reached as high as $739.8 million in Q4 2025 and fell as low as -$98.5 million in Q3 2022.
• Historically, Common Equity has averaged $367.3 million across 5 years, with a median of $371.2 million in 2023.
• Across the five-year window, Common Equity slumped 169.95% in 2022 and soared 548.44% in 2023, its largest moves.
• Year by year, Common Equity stood at $176.6 million in 2022, then jumped by 95.43% to $345.1 million in 2023, then grew by 28.53% to $443.6 million in 2024, then surged by 66.78% to $739.8 million in 2025, then decreased by 6.95% to $688.4 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $688.4 million in Q1 2026, $739.8 million in Q4 2025, and $573.4 million in Q3 2025.